Outcomes of postchemotherapy retroperitoneal lymph node dissection following high‐dose chemotherapy with stem cell transplantation

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|121|24|4369-4375

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.24, 2015-12, pp. : 4369-4375

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Allogeneic Cell-Mediated Immunotherapy at the Stage of Minimal Residual Disease following High-Dose Chemotherapy Supported by Autologous Stem Cell Transplantation

By  

Acta Haematologica, Vol. 114, Iss. 4, 2005-11 ,pp. : 214-220

Karger

Access to resources Recommend Favorite

Clinical outcomes and histological findings of patients with advanced metastatic germ cell tumors undergoing post‐chemotherapy resection of retroperitoneal lymph nodes and residual extraretroperitoneal masses

By  

INTERNATIONAL JOURNAL OF UROLOGY, Vol. 22, Iss. 7, 2015-07 ,pp. : 663-668

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is high-dose chemotherapy with autologous hematopoietic stem cell transplantation in breast cancer patients a done deal?

By Cheng Yee Chung   Ueno Naoto T  

Women's Health, Vol. 6, Iss. 4, 2010-07 ,pp. : 481-485

Future Medicine

Access to resources Recommend Favorite

High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation: The Lymphoma Experience and Its Potential Relevance to Solid Tumors

By  

Oncology, Vol. 58, Iss. 3, 2000-04 ,pp. : 198-206

Karger

Access to resources Recommend Favorite

High-Dose Chemotherapy with Hematopoietic Stem Cell Transplantation for Patients with Advanced Multiple Myeloma

By  

Oncology Research and Treatment, Vol. 23, Iss. 3, 2000-07 ,pp. : 272-274

Karger

Access to resources Recommend Favorite